Avian (Bird) Flu Vaccine Study | Central Kentucky Research
AMR performs phase I, II, III, and IV clinical research trials to support pharmaceutical companies in the development of new drugs, devices, and vaccines at 17 locations across the United States. Over 24 years ago, AMR owners began collaborating based on their mutual respect and shared values. Relationships are the foundation of AMR’s success. Our flexible solutions propel clinical trials from ideas to reality through relationships with industry experts you know. To learn more about AMR’s fully integrated network, click here: amrllc.com.

CKRA News

Avian (Bird) Flu Vaccine Study

  • March 8, 2018

 

This study has now reached maximum enrollment, if you would please fill out an enrollment form we will be happy to contact you and place you on a waiting list, or see if you may be interested in one of our other studies that are still enrolling. Thank you so much for your interest in studies here at Central Kentucky Research!

The purpose of this study is to evaluate an investigational avian (bird) flu vaccine administered intramuscularly with either one of two adjuvants, which are used to help boost one’s immune response.

Duration:  Up to 1 1/2 years

Number of visits to CKRA:  Up to 16

Compensation:  $100 per completed clinic visit.

Note:  Qualified participants must be between the ages of 18 and 49 years of age, be in general good health, and not have a suppressed or compromised immune system.  Other criteria also apply.

Whether you are considering volunteering for one of our clinical research trials or looking for a research partner, we are at your service and ready to build a relationship with you. At CKRA, we believe relationships matter!

Central Kentucky Research Associates, Inc. is a BBB Accredited Medical Testing Company in Lexington, KY
Add Widget Column 2

AMR performs phase I, II, III, and IV clinical research trials to support pharmaceutical companies in the development of new drugs, devices, and vaccines at 17 locations across the United States. Over 24 years ago, AMR owners began collaborating based on their mutual respect and shared values. Relationships are the foundation of AMR’s success. Our flexible solutions propel clinical trials from ideas to reality through relationships with industry experts you know.